권호기사보기
기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
---|
대표형(전거형, Authority) | 생물정보 | 이형(異形, Variant) | 소속 | 직위 | 직업 | 활동분야 | 주기 | 서지 | |
---|---|---|---|---|---|---|---|---|---|
연구/단체명을 입력해주세요. |
|
|
|
|
|
* 주제를 선택하시면 검색 상세로 이동합니다.
Contents
Unusual biclonal IgA plasma cell myeloma with aberrant expression of high-risk immunophenotypes : first report of a new diagnostic and clinical challenge / Carlos A. Monroig-Rivera ; Clara N. Finch Cruz 1
[요약] 1
CASE REPORT 1
DISCUSSION 2
Author Contributions 5
References 6
번호 | 참고문헌 | 국회도서관 소장유무 |
---|---|---|
1 | Habermehl GK, Nakashima MO, Cotta CV. IgA plasma cell neoplasms are characterized by poorer long-term survival and increased genomic complexity compared to IgG neoplasms. Ann Diagn Pathol 2020; 44: 151449. | 미소장 |
2 | McKenna RW, Kroft SH, Linden MA. Plasma cell neoplasms. In:Jaffe ES, Arber DA, Campo E, Harris NL, Quintanilla-Martinez L, eds. Hematopathology. 2nd ed. Philadelphia: Elsevier, 2017; 473-506. | 미소장 |
3 | Rajkumar SV. Multiple myeloma: 2020 update on diagnosis, riskstratification and management. Am J Hematol 2020; 95: 548-67. | 미소장 |
4 | Palumbo A, Avet-Loiseau H, Oliva S, et al. Revised International Staging System for Multiple Myeloma: a report from International Myeloma Working Group. J Clin Oncol 2015; 33: 2863-9. | 미소장 |
5 | Thiele J, Kvasnicka HM, Facchetti F, Franco V, van der Walt J, Orazi A. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 2005; 90: 1128-32. | 미소장 |
6 | Willrich MA, Katzmann JA. Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias. Clin Chem Lab Med 2016; 54: 907-19. | 미소장 |
7 | Keren DF, Schroeder L. Challenges of measuring monoclonal proteins in serum. Clin Chem Lab Med 2016; 54: 947-61. | 미소장 |
8 | Rossi F, Petrucci MT, Guffanti A, et al. Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance. Clin Cancer Res 2009; 15: 4439-45. | 미소장 |
9 | Cardona-Benavides IJ, de Ramon C, Gutierrez NC. Genetic abnormalities in multiple myeloma: prognostic and therapeutic implications. Cells 2021; 10: 336. | 미소장 |
10 | Annibali O, Marchesi F, Petrucci MT, Tirindelli MC, Avvisati G. Relapse of IgA lambda multiple myeloma presenting as obstructive jaundice and abdominal pain. Onkologie 2009; 32: 119-21. | 미소장 |
11 | Cerqueira A, Seco T, Paiva D, Martins H, Cotter J. Acute kidney failure:when multiple myeloma doesn’t give additional clues. Cureus 2020; 12: e7664. | 미소장 |
12 | Suo L, Liu S, Vega I, Thrall M. Extramedullary multiple myeloma involving the liver and periportal lymph node, diagnosed by EUSFNA in a patient with cirrhosis. Diagn Cytopathol 2020; 48: 657-61. | 미소장 |
13 | Yamane F, Ohta R, Sano C. Left lower abdominal pain as an initial symptom of multiple myeloma. Cureus 2021; 13: e20652. | 미소장 |
14 | Muchtar E, Gertz MA. The colorful landscape of multiple myeloma. Leuk Lymphoma 2019; 60: 2099-100. | 미소장 |
15 | Ning X, Wei Y, Wei X, et al. CD43 expression is an adverse prognostic factor in newly diagnosed multiple myeloma. Blood 2021; 138(Suppl 1): 4753. | 미소장 |
16 | Toman I, Loree J, Klimowicz AC, et al. Expression and prognostic significance of Oct2 and Bob1 in multiple myeloma: implications for targeted therapeutics. Leuk Lymphoma 2011; 52: 659-67. | 미소장 |
17 | Kodali S, Yu H, Cerny J. Assessing MYC expression in multiple myeloma. J Hematol Thrombo Dis 2015; 3: e119. | 미소장 |
18 | Castaneda-Avila MA, Ortiz-Ortiz KJ, Torres-Cintron CR, Birmann BM, Epstein MM. Trends in cause of death among patients with multiple myeloma in Puerto Rico and the United States SEER population, 1987-2013. Int J Cancer 2020; 146: 35-43. | 미소장 |
*표시는 필수 입력사항입니다.
*전화번호 | ※ '-' 없이 휴대폰번호를 입력하세요 |
---|
기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
---|
번호 | 발행일자 | 권호명 | 제본정보 | 자료실 | 원문 | 신청 페이지 |
---|
도서위치안내: 정기간행물실(524호) / 서가번호: 국내17
2021년 이전 정기간행물은 온라인 신청(원문 구축 자료는 원문 이용)
우편복사 목록담기를 완료하였습니다.
*표시는 필수 입력사항입니다.
저장 되었습니다.